Literature DB >> 28189587

Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression.

Pedro A Lazo1.   

Abstract

The activation of p53 in response to different types of cellular stress induces several protective reactions including cell cycle arrest, senescence or cell death. These protective effects are a consequence of the activation of p53 by specific phosphorylation performed by several kinases. The reversion of the cell cycle arrest, induced by p53, is a consequence of the phosphorylated and activated p53, which triggers its own downregulation and that of its positive regulators. The different down-regulatory processes have a sequential and temporal order of events. The mechanisms implicated in p53 down-regulation include phosphatases, deacetylases, and protein degradation by the proteasome or autophagy, which also affect different p53 protein targets and functions. The necessary first step is the dephosphorylation of p53 to make it available for interaction with mdm2 ubiquitin-ligase, which requires the activation of phosphatases targeting both p53 and p53-activating kinases. In addition, deacetylation of p53 is required to make lysine residues accessible to ubiquitin ligases. The combined action of these downregulatory mechanisms brings p53 protein back to its basal levels, and cell cycle progression can resume if cells have overcome the stress or damage situation. The specific targeting of these down-regulatory mechanisms can be exploited for therapeutic purposes in cancers harbouring wild-type p53.
Copyright © 2017 The Author. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Deacetylase; Kinases; Phosphatases; Proteasome; p53

Mesh:

Substances:

Year:  2017        PMID: 28189587     DOI: 10.1016/j.cellsig.2017.02.005

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  15 in total

1.  Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.

Authors:  Gang Xi; Xinchun Shen; Christine Wai; Morris F White; David R Clemmons
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

2.  Expression of MDM2 in Macrophages Promotes the Early Postentry Steps of HIV-1 Infection through Inhibition of p53.

Authors:  Yann Breton; Vincent Desrosiers; Michel Ouellet; Alexandre Deshiere; Cynthia Torresilla; Éric A Cohen; Michel J Tremblay
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 3.  A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.

Authors:  Jessica J Miller; Kalvin Kwan; Christian Gaiddon; Tim Storr
Journal:  J Biol Inorg Chem       Date:  2022-04-30       Impact factor: 3.862

Review 4.  MicroRNA Regulation of Oxidative Stress-Induced Cellular Senescence.

Authors:  Huaije Bu; Sophia Wedel; Maria Cavinato; Pidder Jansen-Dürr
Journal:  Oxid Med Cell Longev       Date:  2017-05-16       Impact factor: 6.543

Review 5.  Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?

Authors:  Ignacio Campillo-Marcos; Pedro A Lazo
Journal:  Cell Mol Life Sci       Date:  2018-04-20       Impact factor: 9.261

Review 6.  p53: key conductor of all anti-acne therapies.

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2017-09-19       Impact factor: 5.531

7.  Novel roles of ER stress in repressing neural activity and seizures through Mdm2- and p53-dependent protein translation.

Authors:  Dai-Chi Liu; Daphne E Eagleman; Nien-Pei Tsai
Journal:  PLoS Genet       Date:  2019-09-26       Impact factor: 5.917

8.  p53 modifications: exquisite decorations of the powerful guardian.

Authors:  Yanqing Liu; Omid Tavana; Wei Gu
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

9.  Bifunctional ligand design for modulating mutant p53 aggregation in cancer.

Authors:  Jessica J Miller; Anaïs Blanchet; Christophe Orvain; Lucienne Nouchikian; Yasmin Reviriot; Ryan M Clarke; Diego Martelino; Derek Wilson; Christian Gaiddon; Tim Storr
Journal:  Chem Sci       Date:  2019-10-07       Impact factor: 9.825

Review 10.  The nucleolus, an ally, and an enemy of cancer cells.

Authors:  Dariusz Stępiński
Journal:  Histochem Cell Biol       Date:  2018-08-13       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.